Matthew McManus
Vermögen: 397 471 $ am 31.05.2026
Vermögen: 397 471 $ am 31.05.2026
Matthew F.
McManus is currently Chairman at Ansa Biotechnologies, Inc. since 2023.
Former roles include President, Chief Executive Officer & Director at PrimeraDx, Inc. from 2010 to 2014; President, Chief Executive Officer & Director at Asuragen, Inc. from 2014 to 2021; Chief Operating Officer & Executive Vice President at Azenta, Inc. in 2022; COO-Pathology and Laboratory Medicine Institute at The Cleveland Clinic Foundation in 2010; President-Diagnostics & Spatial Biology Segment at Bio-Techne Corp.
from 2024 to 2026; Manager-Business Unit at Procter & Gamble Co.; Management Consultant at McKinsey & Co., Inc.; and Medical Scientist at Novartis Institutes for Biomedical Research, Inc. Education includes undergraduate studies at College of the Holy Cross (Massachusetts), an MBA from Boston College, and a doctorate from the University of Pennsylvania Medical Center.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2026 | 7 691 ( 0 % ) | 397 471 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc. BiotechnologyHealth Technology Develops novel DNA synthesis technology | Vorsitzender | 22.02.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| BIO-TECHNE CORPORATION | Corporate Officer/Principal | 01.03.2026 |
| AZENTA, INC. | Geschäftsführer | 14.10.2022 |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Vorstandsvorsitzender | - |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Corporate Officer/Principal | 02.01.2010 |
| PROCTER & GAMBLE COMPANY | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Procter & Gamble Co.
Procter & Gamble Co. Household/Personal CareConsumer Non-Durables Manufactures and sells fabric & home care products, diapers, baby wipes, tissues, toilet paper, hair, skin and personal care, toothbrushes, vitamins, supplements & razors | Consumer Non-Durables |
Bio-Techne Corp.
Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Azenta, Inc.
Azenta, Inc. Medical/Nursing ServicesHealth Services Provides gene sequencing and gene synthesis services and develops automated ultra-cold storage systems | Health Services |
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology Develops and commercializes molecular diagnostics systems | Health Technology |
Asuragen, Inc.
Asuragen, Inc. Medical SpecialtiesHealth Technology Develops molecular diagnostic products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
College of the Holy Cross (Massachusetts)
College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Conducts biomedical researches | Commercial Services |
The Cleveland Clinic Foundation
The Cleveland Clinic Foundation Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
University of Pennsylvania Medical Center
University of Pennsylvania Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ansa Biotechnologies, Inc.
Ansa Biotechnologies, Inc. BiotechnologyHealth Technology Develops novel DNA synthesis technology | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen